EU Clinical Trial 2018-000752-18

Ajmaline provocation in asymptomatic PLN and PKP2 mutation carriers for early detection of Arrhythmogenic Cardiomyopathy  Feb 19, 2019

Main objective of the trial: Describe the electrocardiographic changes and areas of late myocardial activation encountered in PLN and PKP2 mutation carriers, patients and controles during ajmaline provocation . And use this information for the detection of early stages of arrhythmogenic cardiomyopathy

Parties

Sponsors
Countries
DE
Keywords
Ajmaline Gilurytmal

JSON preview

Similar records

Title

Source:  EMA Last updated:  May 30, 2019

From ClinicalTrialsRegister.eu, a database of the European Medicines Agency. This record may not reflect the most current and accurate data available from the EMA.